TFA
FDMT icon

Toth Financial Advisory’s 4D Molecular Therapeutics FDMT Stock Holding History

Toth Financial Advisory’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$28.6K Buy
+2,000
New +$26K ﹤0.01% 460

Other funds holding FDMT

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
PS
Planning Strategies Lancaster, Pennsylvania $169M AUM
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Toth Financial Advisory's FDMT Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in 4D Molecular Therapeutics (FDMT) in Q3 2026: 2,000 shares worth $28.6K. The stake represents ﹤0.01% of the portfolio and ranks #460 among its holdings.

5 funds tracked by Wall St. Rank hold FDMT as of Q3 2026.

  • Toth Financial Advisory held 2,000 shares of 4D Molecular Therapeutics worth $28.6K as of Q3 2026.
  • 4D Molecular Therapeutics was a new Toth Financial Advisory position in Q3 2026.
  • 4D Molecular Therapeutics made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #460 holding.
  • 5 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.